C. Garzoni

Discipline

Economies et finances (3) Sociologie (2) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (23)

Co-auteur

Date

Source

Mot-clé

cohorte (17) Patients (16) Patients (16) infection (15) Human beings (15) Infection (15) Swiss (14) organe (13) Ci (Chinese poetry) (13) Organ (Musical instrument) (13) Organs (13) orgue (13) Treatment (9) Months (9) Infections (9) Transplantation (9) temps (durée) (8) risque (8) Time (8) Risk (8) Diseases (8) maladie (8) thérapie (7) mortalité (7) maladie (7) taux (7) Mortality (7) Therapeutics (7) Mortality (7) Lungs (7)

Documents écrit par C. Garzoni (23) | parle de C. Garzoni (0)

Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
K. Kusejko et al.
Patient leaflets on respiratory tract infections did not improve shared decision making and antibiotic prescriptions in a low-prescriber setting.
A. Plate et al. (29 févr. 2024)
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial).
M. Mombelli et al. (25 janv. 2024)
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
L.N. Walti et al. (3 avr. 2023)
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study.
A. Lenoir et al. (2023)
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients.
T.T. Pham et al.
Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study.
L. van den Bogaart et al.
Frailty assessment for COVID-19 follow-up: a prospective cohort study.
I. Müller et al.
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
L. van den Bogaart et al.
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
L.N. Walti et al.
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study.
S.A. Guler et al.
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study.
C. van Delden et al. (23 oct. 2020)
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.
A.T. Coste et al.
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
J. Tschopp et al.
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
A. Cusini et al.
Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
P.W. Schreiber et al. (2018)
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.
M. Stern et al.
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
D. Héquet et al. (2016)
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
A. Wójtowicz et al. (2015)
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
O. Manuel et al. (2015)
Reply to Cunha et al.
A. Wójtowicz et al. (2015)
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
O. Manuel et al. (2013)
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
N. Khanna et al. (2009)